BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38754239)

  • 1. Microchimeric cells promote production of rheumatoid arthritis-specific autoantibodies.
    Hemon M; Giassi M; Ghaffar Y; Martin M; Roudier J; Auger I; Lambert NC
    J Autoimmun; 2024 Jun; 146():103238. PubMed ID: 38754239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptidyl arginine deiminase immunization induces anticitrullinated protein antibodies in mice with particular MHC types.
    Arnoux F; Mariot C; Peen E; Lambert NC; Balandraud N; Roudier J; Auger I
    Proc Natl Acad Sci U S A; 2017 Nov; 114(47):E10169-E10177. PubMed ID: 29109281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAD2 immunization induces ACPA in wild-type and HLA-DR4 humanized mice.
    Hemon MF; Lambert NC; Roudier J; Auger I
    Eur J Immunol; 2022 Sep; 52(9):1464-1473. PubMed ID: 35712879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptidylarginine Deiminase Autoimmunity and the Development of Anti-Citrullinated Protein Antibody in Rheumatoid Arthritis: The Hapten-Carrier Model.
    Auger I; Balandraud N; Massy E; Hemon MF; Peen E; Arnoux F; Mariot C; Martin M; Lafforgue P; Busnel JM; Roudier J
    Arthritis Rheumatol; 2020 Jun; 72(6):903-911. PubMed ID: 31820586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis.
    Feitsma AL; van der Voort EI; Franken KL; el Bannoudi H; Elferink BG; Drijfhout JW; Huizinga TW; de Vries RR; Toes RE; Ioan-Facsinay A
    Arthritis Rheum; 2010 Jan; 62(1):117-25. PubMed ID: 20039411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAD4 Immunization Triggers Anti-Citrullinated Peptide Antibodies in Normal Mice: Analysis With Peptide Arrays.
    Hemon MF; Lambert NC; Arnoux F; Roudier J; Auger I
    Front Immunol; 2022; 13():840035. PubMed ID: 35432329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of autoantibodies to citrullinated BiP in rheumatoid arthritis patients and pro-inflammatory role of citrullinated BiP in collagen-induced arthritis.
    Shoda H; Fujio K; Shibuya M; Okamura T; Sumitomo S; Okamoto A; Sawada T; Yamamoto K
    Arthritis Res Ther; 2011; 13(6):R191. PubMed ID: 22108001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 'shared epitope' alleles.
    Wagner CA; Sokolove J; Lahey LJ; Bengtsson C; Saevarsdottir S; Alfredsson L; Delanoy M; Lindstrom TM; Walker RP; Bromberg R; Chandra PE; Binder SR; Klareskog L; Robinson WH
    Ann Rheum Dis; 2015 Mar; 74(3):579-86. PubMed ID: 24297382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific Association of HLA-DRB1*03 With Anti-Carbamylated Protein Antibodies in Patients With Rheumatoid Arthritis.
    Regueiro C; Rodriguez-Rodriguez L; Triguero-Martinez A; Nuño L; Castaño-Nuñez AL; Villalva A; Perez-Pampin E; Lopez-Golan Y; Abasolo L; Ortiz AM; Herranz E; Pascual-Salcedo D; Martínez-Feito A; Boveda MD; Gomez-Reino JJ; Martín J; Gonzalez-Escribano MF; Fernandez-Gutierrez B; Balsa A; Gonzalez-Alvaro I; Gonzalez A
    Arthritis Rheumatol; 2019 Mar; 71(3):331-339. PubMed ID: 30277011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-citrullinated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients.
    Barra L; Scinocca M; Saunders S; Bhayana R; Rohekar S; Racapé M; Coles R; Cairns E; Bell DA
    Arthritis Rheum; 2013 Jun; 65(6):1439-47. PubMed ID: 23450693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different Hierarchies of Anti-Modified Protein Autoantibody Reactivities in Rheumatoid Arthritis.
    Sahlström P; Hansson M; Steen J; Amara K; Titcombe PJ; Forsström B; Stålesen R; Israelsson L; Piccoli L; Lundberg K; Klareskog L; Mueller DL; Catrina AI; Skriner K; Malmström V; Grönwall C
    Arthritis Rheumatol; 2020 Oct; 72(10):1643-1657. PubMed ID: 32501655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of a rheumatoid arthritis protective sequence when acquired through microchimerism.
    Kanaan SB; Sensoy O; Yan Z; Gadi VK; Richardson ML; Nelson JL
    Proc Natl Acad Sci U S A; 2019 Sep; 116(39):19600-19608. PubMed ID: 31501349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-citrullinated peptide autoantibodies, human leukocyte antigen shared epitope and risk of future rheumatoid arthritis: a nested case-control study.
    Arkema EV; Goldstein BL; Robinson W; Sokolove J; Wagner CA; Malspeis S; Rosner B; Grodstein F; Karlson EW; Costenbader KH
    Arthritis Res Ther; 2013 Oct; 15(5):R159. PubMed ID: 24286474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence and role of anti-citrullinated protein antibodies in experimental arthritis models.
    Cantaert T; Teitsma C; Tak PP; Baeten D
    Arthritis Rheum; 2013 Apr; 65(4):939-48. PubMed ID: 23280233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential ACPA Binding to Nuclear Antigens Reveals a PAD-Independent Pathway and a Distinct Subset of Acetylation Cross-Reactive Autoantibodies in Rheumatoid Arthritis.
    Lloyd KA; Wigerblad G; Sahlström P; Garimella MG; Chemin K; Steen J; Titcombe PJ; Marklein B; Zhou D; Stålesen R; Ossipova E; Lundqvist C; Ekwall O; Rönnelid J; Mueller DL; Karlsson MCI; Kaplan MJ; Skriner K; Klareskog L; Wermeling F; Malmström V; Grönwall C
    Front Immunol; 2018; 9():3033. PubMed ID: 30662440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-citrullinated peptides as autoantigens in rheumatoid arthritis-relevance to treatment.
    Sakkas LI; Bogdanos DP; Katsiari C; Platsoucas CD
    Autoimmun Rev; 2014 Nov; 13(11):1114-20. PubMed ID: 25182207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Bone Mineral Density and Autoantibodies in Patients With Rheumatoid Arthritis.
    Amkreutz JAMP; de Moel EC; Theander L; Willim M; Heimans L; Nilsson JÅ; Karlsson MK; Huizinga TWJ; Åkesson KE; Jacobsson LTH; Allaart CF; Turesson C; van der Woude D
    Arthritis Rheumatol; 2021 Jun; 73(6):921-930. PubMed ID: 33314699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Rheumatoid Arthritis Patients, HLA-DRB1*04:01 and Rheumatoid Nodules Are Associated With ACPA to a Particular Fibrin Epitope.
    Larid G; Pancarte M; Offer G; Clavel C; Martin M; Pradel V; Auger I; Lafforgue P; Roudier J; Serre G; Balandraud N
    Front Immunol; 2021; 12():692041. PubMed ID: 34248985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comprehensive Evaluation of the Relationship Between Different IgG and IgA Anti-Modified Protein Autoantibodies in Rheumatoid Arthritis.
    Grönwall C; Liljefors L; Bang H; Hensvold AH; Hansson M; Mathsson-Alm L; Israelsson L; Joshua V; Svärd A; Stålesen R; Titcombe PJ; Steen J; Piccoli L; Sherina N; Clavel C; Svenungsson E; Gunnarsson I; Saevarsdottir S; Kastbom A; Serre G; Alfredsson L; Malmström V; Rönnelid J; Catrina AI; Lundberg K; Klareskog L
    Front Immunol; 2021; 12():627986. PubMed ID: 34093522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss.
    Krishnamurthy A; Joshua V; Haj Hensvold A; Jin T; Sun M; Vivar N; Ytterberg AJ; Engström M; Fernandes-Cerqueira C; Amara K; Magnusson M; Wigerblad G; Kato J; Jiménez-Andrade JM; Tyson K; Rapecki S; Lundberg K; Catrina SB; Jakobsson PJ; Svensson C; Malmström V; Klareskog L; Wähämaa H; Catrina AI
    Ann Rheum Dis; 2016 Apr; 75(4):721-9. PubMed ID: 26612338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.